These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1210 related articles for article (PubMed ID: 28440523)

  • 21. Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control.
    Habr-Gama A; Gama-Rodrigues J; São Julião GP; Proscurshim I; Sabbagh C; Lynn PB; Perez RO
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):822-8. PubMed ID: 24495589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rational evaluation of the complete response after neoadjuvant therapy in locally advanced mid-low rectal cancer: the pros and cons of "watch and wait" strategy].
    Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):507-513. PubMed ID: 31238630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer.
    Creavin B; Ryan E; Martin ST; Hanly A; O'Connell PR; Sheahan K; Winter DC
    Br J Cancer; 2017 Jan; 116(2):169-174. PubMed ID: 27997526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
    Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy, surgery, or "watch and wait".
    Lai CL; Lai MJ; Wu CC; Jao SW; Hsiao CW
    Int J Colorectal Dis; 2016 Feb; 31(2):413-9. PubMed ID: 26607907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of wait and see strategy versus radical surgery and local excision for rectal cancer with cCR response after neoadjuvant chemoradiotherapy: a meta-analysis.
    Zhao GH; Deng L; Ye DM; Wang WH; Yan Y; Yu T
    World J Surg Oncol; 2020 Aug; 18(1):232. PubMed ID: 32862826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcomes of real world 'watch and wait' data for rectal cancer after neoadjuvant chemoradiotherapy.
    Simpson G; Hopley P; Wilson J; Day N; Haworth A; Montazeri A; Smith D; Titu L; Anderson J; Agbamu D; Walsh C
    Colorectal Dis; 2020 Nov; 22(11):1568-1576. PubMed ID: 32686268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Locally advanced rectal cancer: Preliminary results of rectal preservation after neoadjuvant chemoradiotherapy.
    Vaccaro CA; Yazyi FJ; Ojra Quintana G; Santino JP; Sardi ME; Beder D; Tognelli J; Bonadeo F; Lastiri JM; Rossi GL
    Cir Esp; 2016 May; 94(5):274-9. PubMed ID: 26980259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes after the watch-and-wait strategy and local excision treatment for rectal cancer: a meta-analysis.
    Li J; Ma Y; Wen L; Zhang G; Yao X
    Expert Rev Anticancer Ther; 2023 May; 23(5):555-564. PubMed ID: 36795784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
    Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
    Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [An initial exploration of the application of transanal endoscopic microsurgery in rectal cancer patients with clinical complete response after neoadjuvant chemoradiotherapy].
    Xue XQ; Zhou JL; Lin GL; Bai XS; Xiao Y; Wu B; Qiu HZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):560-565. PubMed ID: 31238635
    [No Abstract]   [Full Text] [Related]  

  • 32. Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer.
    Alvarez JA; Shi Q; Dasari A; Garcia-Aguilar J; Sanoff H; George TJ; Hong T; Yothers G; Philip P; Nelson G; Al Baghdadi T; Alese OB; Zambare W; Omer D; Verheij FS; Bercz A; Kim MJ; Buckley J; Williams H; George M; Garcia R; Gallagher P; O'Reilly EM; Meyerhardt JA; Crawley J; Shergill A; Horvat N; Romesser PB; Hall W; Smith JJ
    BMC Cancer; 2024 Jul; 24(1):901. PubMed ID: 39060961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome and Salvage Surgery Following "Watch and Wait" for Rectal Cancer after Neoadjuvant Therapy: A Systematic Review.
    Kong JC; Guerra GR; Warrier SK; Ramsay RG; Heriot AG
    Dis Colon Rectum; 2017 Mar; 60(3):335-345. PubMed ID: 28177997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis.
    Dossa F; Chesney TR; Acuna SA; Baxter NN
    Lancet Gastroenterol Hepatol; 2017 Jul; 2(7):501-513. PubMed ID: 28479372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoradiation and consolidation chemotherapy for rectal cancer provides a high rate of organ preservation with a very good long-term oncological outcome: a single-center cohort series.
    Asoglu O; Bulut A; Aliyev V; Piozzi GN; Guven K; Bakır B; Goksel S
    World J Surg Oncol; 2022 Nov; 20(1):358. PubMed ID: 36352416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study.
    Fernandez LM; São Julião GP; Figueiredo NL; Beets GL; van der Valk MJM; Bahadoer RR; Hilling DE; Meershoek-Klein Kranenbarg E; Roodvoets AGH; Renehan AG; van de Velde CJH; Habr-Gama A; Perez RO;
    Lancet Oncol; 2021 Jan; 22(1):43-50. PubMed ID: 33316218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Reassessment of practice of Chinese surgeons since introduction of the watch and wait strategy after neoadjuvant therapy for rectal cancer].
    Zhao MH; Sun TT; Wang L; Huang YL; Xie XY; Lu Y; Zhao GH; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):383-394. PubMed ID: 38644244
    [No Abstract]   [Full Text] [Related]  

  • 38. [Current status and perspectives on "watch and wait" strategy for rectal cancer patients after clinical complete response following neoadjuvant chemoradiation].
    Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):521-526. PubMed ID: 31238632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conditional Survival in Patients With Rectal Cancer and Complete Clinical Response Managed by Watch and Wait After Chemoradiation: Recurrence Risk Over Time.
    São Julião GP; Karagkounis G; Fernandez LM; Habr-Gama A; Vailati BB; Dattani M; Kalady MF; Perez RO
    Ann Surg; 2020 Jul; 272(1):138-144. PubMed ID: 30946085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy.
    Smith JJ; Strombom P; Chow OS; Roxburgh CS; Lynn P; Eaton A; Widmar M; Ganesh K; Yaeger R; Cercek A; Weiser MR; Nash GM; Guillem JG; Temple LKF; Chalasani SB; Fuqua JL; Petkovska I; Wu AJ; Reyngold M; Vakiani E; Shia J; Segal NH; Smith JD; Crane C; Gollub MJ; Gonen M; Saltz LB; Garcia-Aguilar J; Paty PB
    JAMA Oncol; 2019 Apr; 5(4):e185896. PubMed ID: 30629084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.